Severe Radiation-Induced Lymphopenia Affects the Outcomes of Esophageal Cancer: A Comprehensive Systematic Review and Meta-Analysis

Severe Radiation-Induced Lymphopenia Affects the Outcomes of Esophageal Cancer: A Comprehensive Systematic Review and Meta-Analysis

The aim of the current study was to evaluate the influence of severe radiation-induced lymphopenia (RIL) on the outcomes of esophageal cancer (EC). A systematic review and meta-analysis was performed through the PRISMA guideline. Seventeen studies were included in the current systematic review, with...

Full description

Bibliographic Details
Main Authors:	Dongjun Dai, Qiaoying Tian, Genhua Yu, Yongjie Shui, Hao Jiang, Qichun Wei
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	Cancers
Subjects:	esophageal cancer radiation therapy lymphopenia pathologic complete response survival outcomes effective dose to the immune cells
Online Access:	https://www.mdpi.com/2072-6694/14/12/3024

Similar Items

Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma
by: Jianjian Qiu, et al.
Published: (2023-05-01)

Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC
by: Wang Jing, MD, et al.
Published: (2022-09-01)

Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients
by: Saba Ebrahimi, BSc, et al.
Published: (2021-04-01)

Radiation-induced lymphopenia and the survival of women with cervical cancer: a meta-analysis
by: Hongming Cao, et al.
Published: (2023-12-01)

The Clinical Value of Comprehensive Nursing Intervention in Preventing Severe Lymphopenia and Improving the Survival Rate Among Patients with Sepsis
by: Zhang L, et al.
Published: (2023-10-01)

A Systematic Review and Meta-analysis of the Impact of Radiation-Related Lymphopenia on Outcomes in High-Grade Gliomas
by: Supriya Mallick, et al.
Published: (2022-10-01)

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
by: Francesca Cottini, et al.
Published: (2021-02-01)

Possible Mechanisms of Lymphopenia in Severe Tuberculosis
by: Fei Li, et al.
Published: (2023-10-01)

Effect of intensity modulated radiotherapy on lymphocytes in patients with esophageal squamous cell carcinoma and its clinical significance
by: Xiufang Tian, et al.
Published: (2023-03-01)

CT-based dosiomics and radiomics model predicts radiation-induced lymphopenia in nasopharyngeal carcinoma patients
by: Qingfang Huang, et al.
Published: (2023-10-01)

Lymphopenia: A predictive marker of disease severity in COVID-19 infection
by: Georgeta Daniela Georgescu, et al.
Published: (2021-12-01)

Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients
by: María Martínez-Urbistondo, et al.
Published: (2021-08-01)

Influence of treatment-related lymphopenia on the efficacy of immune checkpoint inhibitors in lung cancer: a meta-analysis
by: Ye Zhang, et al.
Published: (2023-12-01)

Pericardial irradiation dose may be strongly associated with grade 4 lymphopenia and affect prognosis in patients with locally advanced esophageal cancer receiving definitive concurrent chemoradiotherapy
by: Xianyan Chen, et al.
Published: (2023-09-01)

The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
by: Huilai Lv, et al.
Published: (2023-01-01)

Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma
by: Weiming Han, et al.
Published: (2022-11-01)

Is Lymphopenia a Predictor of Mortality in Patients with COVID-19?
by: Jehat Kılıc, et al.
Published: (2023-01-01)

Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity
by: Ting-Ting Sheu, et al.
Published: (2021-04-01)

Beyond lymphopenia, unraveling radiation-induced leucocyte subpopulation kinetics and mechanisms through modeling approaches
by: Thao-Nguyen Pham, et al.
Published: (2023-02-01)

High prevalence of infections in non-COVID-19 patients admitted to the Emergency Department with severe lymphopenia
by: Arthur Baïsse, et al.
Published: (2022-03-01)

Neural network based ensemble model to predict radiation induced lymphopenia after concurrent chemo-radiotherapy for non-small cell lung cancer from two institutions
by: Yejin Kim, et al.
Published: (2023-05-01)

Lymphopenia and Early Variation of Lymphocytes to Predict In-Hospital Mortality and Severity in ED Patients with SARS-CoV-2 Infection
by: Maxence Simon, et al.
Published: (2022-03-01)

Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer
by: Akiyuki Wakita, et al.
Published: (2023-11-01)

Bystander Effects and Unintended Consequences: Time to Include the Spleen in Radiation Therapy Planning
by: Matthew S. Katz
Published: (2020-07-01)

Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients
by: A. M. Saeed, et al.
Published: (2024-03-01)

Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma
by: Dirk Tomsitz, et al.
Published: (2022-07-01)

Combined modality therapy for patients with esophageal squamous cell carcinoma: Radiation dose and survival analyses
by: Pei‐Wei Shueng, et al.
Published: (2023-01-01)

Cardiac Dose Predicts the Response to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
by: Yu-Chieh Ho, et al.
Published: (2023-09-01)

Lymphopenia Caused by Virus Infections and the Mechanisms Beyond
by: Zijing Guo, et al.
Published: (2021-09-01)

Is Lymphopenia Detected in Sarcoidosis Associated with the Disease Activity?
by: Coşkun Doğan, et al.
Published: (2019-07-01)

Prognostic Effect of the Dose of Radiation Therapy and Extent of Lymphadenectomy in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma
by: Chu-Pin Pai, et al.
Published: (2022-08-01)

Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models
by: Peter S. N. van Rossum, et al.
Published: (2023-11-01)

Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs
by: Daphne S. Bakker, et al.
Published: (2018-10-01)

The effect of gastric fundus radiation dose on postoperative anastomotic leakage in esophageal cancer
by: Yulia Kundel, et al.
Published: (2023-02-01)

Severe persistent mycobacteria antigen stimulation causes lymphopenia through impairing hematopoiesis
by: Fei Li, et al.
Published: (2023-01-01)

Correlation of Expression of MMP-2, ACE2, and TMPRSS2 Genes with Lymphopenia for Mild and Severity of COVID-19
by: Behrooz Ghezelbash, et al.
Published: (2023-02-01)

CMV Infection and Lymphopenia: Warning Markers of Pneumocystis Pneumonia in Kidney Transplant Recipients
by: Isabelle Eberl, et al.
Published: (2024-01-01)

Association of Lymphopenia with Short Term Outcomes of Sepsis Patients; a Brief Report
by: Hojat Sheikh Motahar Vahedi, et al.
Published: (2019-01-01)

Change in Maximal Esophageal Wall Thickness Provides Prediction of Survival and Recurrence in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy and Surgery
by: Wu Y, et al.
Published: (2021-03-01)

Effect of Lymphopenia on Tumor Response and Clinical Outcomes Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer
by: Deck J, et al.
Published: (2023-05-01)